Cryptococcal Meningitis
Author:
- Jeremy N DayJDJeremy N Day
- 1 October 2004
- journal article
- Published by BMJ in Practical Neurology
- Vol. 4 (5) , 274-285
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Immune Reconstitution Cryptococcosis after Initiation of Successful Highly Active Antiretroviral TherapyClinical Infectious Diseases, 2002
- Cryptococcal infection in a cohort of HIV-1-infected Ugandan adultsAIDS, 2002
- Hybrid genotypes in the pathogenic yeast Cryptococcus neoformansMicrobiology, 2001
- Epidemiology and Host- and Variety-Dependent Characteristics of Infection Due to Cryptococcus neoformans in Australia and New ZealandClinical Infectious Diseases, 2000
- Clinical Utility of Monitoring Serum Cryptococcal Antigen (sCRAG) Titers in Patients with AIDS-Related Cryptococcal DiseaseHIV Research & Clinical Practice, 2000
- Treatment of Cryptococcal Meningitis Associated with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1997
- Molecular Typing of Cryptococcus neoformans: Taxonomic and Epidemiological AspectsInternational Journal of Systematic and Evolutionary Microbiology, 1997
- Administering amphotericin B—a practical approachJournal of Antimicrobial Chemotherapy, 1994
- THE RARITY OF CRYPTOCOCCOSIS IN NORTHERN CALIFORNIA: THE 10-YEAR EXPERIENCE OF A LARGE DEFINED POPULATION1American Journal of Epidemiology, 1983
- A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal MeningitisNew England Journal of Medicine, 1979